Breast Implant Market by Product (Silicone Implants, and Saline Implants), Shape (Round, and Anatomical), Application (Breast Cosmetic Surgery, and Breast Reconstruction Surgery), End User (Hospitals, and Cosmetology Clinics), Regions and Company Analysis 2024-2032

Breast Implant Market Analysis

Breast Implant Market size was valued at US$ 2.32  Billion in 2023. It is projected to increase at a CAGR of 7.51% from 2024 to 2032. Renub Research forecasted the value to be US$ 4.45 Billion by 2032.

Breast implant is a medical procedure performed to breast augment or reconstruct a woman's breasts in a variation of sizes and forms to suit the desires of the patient. They are made up of a silicone outer shell that is either silicone gel or saline filled. Their main applications are in corrective surgery, breast reconstruction, and cosmetic augmentation. For cosmetic purposes, breast augmentation improves breast look. Additionally, breast implants are utilised in breast reconstruction procedures, especially for women who have had mastectomyes because of breast cancer.

Breast Implant Market trends:

Increasing Aesthetic Awareness and desire for Physical Betterment

The market for breast implants is directly impacted by the growing awareness of aesthetics and the desire for physical improvement. More people choose to cosmetic operations to boost their self-esteem and accomplish their desired aesthetic goals as society becomes more focused on looks. Breast implants are in high demand because they provide a solution for those who want to improve the looks and shape of their breasts, which is driven by a growing awareness of the need for physical enhancement.

    According to (IPAPS) International Society of Aesthetic Plastic Surgery, breast Augmentation is the top performed surgical cosmetic procedure among women with 2,131,976 procedures worldwide in 2022.
    Globally, 1,862,506 breast augmentation surgeries were carried out in 2018, indicating a 16.8% increase between 2018 and 2022.
    In United States, 255,200 breast augmentation procedures were performed during 2022.
    243,923 breast augmentation procedures were performed in Brazil during 2022.
    In Japan, 8,238 breast augmentation procedures were performed in 2022.
    In Mexico, the total breast augmentation procedure performed were 103,524 in 2022.

Rise in Number of Breast Cancer Patients

Surgical procedures like mastectomy, which include removing breast tissue, are frequently required for breast cancer patients. Many women who have had mastectomy wish to get breast reconstruction in order to feel more complete and confident in their looks. The market for breast implants is driven by the rising demand for breast reconstruction treatments due to the rising prevalence of breast cancer. The safety, longevity, and cosmetic results of breast restoration have all improved due to developments in breast implant technology, which has increased demand even more.

    In 2022, breast cancer killed 670 000 lives worldwide.
    According to the World Cancer Organization, 12.5% of newly reported instances of cancer each year are breast cancer, making it the most recurring cancer worldwide.
    The most prevalent malignancy in American women's diagnoses is breast cancer. Breast cancer reports for around 30% of all newly diagnosed malignancies in women each year.
    One in eight American women, or almost 13% of all women, will eventually get invasive breast cancer.
    In 2023, there are projected to be 55,720 new cases of DCIS among women and  297,790 fresh instances of invasive breast cancer in the US.    
    As per BCRF estimations, in United States 313,510 individuals will be detected with breast cancer in 2024.

North America Breast Implant Market

In terms of market share for breast implants, North America accounted for a significant share in 2023. The region's growth is attributed to a number of factors, including the advanced healthcare infrastructure presence, the rising use of medical devices, the increased investment in the healthcare sector, the rise in research and development activities and the technological advancement in medical devices. Furthermore, the rising pervasiveness of breast cancer and awareness campaigns regarding breast implants also drives the demand for breast implant surgeries in the region.

    The newest generation of breast implants, with clinically verified low complication rates, is now available to women through Canadian plastic surgeons. Health Canada has licensed Sientra, the first new manufacturer of silicone gel breast implants in almost 20 years. Sientra is distributed by Clarion Medical Technologies. Their High-Strength Cohesive Silicone Gel Breast Implants provide an unparalleled safety profile due to their cutting-edge gel technology and clinically validated results.

Breast Implant Company Analysis:

Some major companies are present in the global breast implant industry. These are Abbvie Inc., Sientra Inc., Hans Biomed Co., Ltd, Establishment Labs SA, Guangzhou Wanhe Plastic Materials Co., Ideal Implant Inc., Laboratoires Arion, Polytech Health & Aesthetics GmbH, Mentor Worldwide LLC and Sebbin.

Breast Implant Company News:

June 2023: Olympus Cosmetic Group, a recently established platform offering comprehensive cosmetic surgery, dermatological treatments, and non-surgical cosmetic procedures, recently received an investment from VSS Capital Partners.
November 2023: Allergan Aesthetics, an AbbVie subsidiary , acknowledges the enormously personal choice that patients experience when selecting breast surgery. The new Natrelle® campaign, "For Every BODY," celebrates patients and their various stories, using new imagery and visual assets. The campaign illustrates how any curve, shape, and BODY can have a personalized look with the Natrelle® breast implant collection.
October 2022: The micro-textured anatomical breast implant LUNA xt, which was allowed under the new European Medical Device Regulation (MDR), was given CE approval to GC Anesthetics.
June 2022: To meet the needs of breast reconstruction, Coll Plant announced the commencement of a research in large animals for its 3D bio-printed regenerative breast implant program.
January 2022: The FDA has granted approval to Mentor Worldwide LLC's MENTO MemoryGel BOOST breast implant for use in breast augmentation in women who are 22 years of age and older.

Product – Market breakup in 2 viewpoints:

1.    Silicone Implants
2.    Saline Implants

Shape – Market breakup in 2 viewpoints:

1.    Round
2.    Anatomical

Application – Market breakup in 2 viewpoints:

1.    Breast Cosmetic Surgery
2.    Breast Reconstruction Surgery

End User – Market breakup in 2 viewpoints:

1.    Hospitals
2.    Cosmetology Clinics

Country – Market breakup of 17 Countries:

1.    United States
2.    Brazil
3.    Japan
4.    Mexico
5.    Turkey
6.    Germany
7.    Argentina
8.    Italy
9.    Colombia
10.    India
11.    Spain
12.    Greece
13.    Iran
14.    Romania
15.    United Kingdom
16.    Thailand
17.    Rest of the World

All the key players have been covered from 4 Viewpoints:

•    Business Overview
•    Product Portfolio
•    Recent Development
•    Revenue Analysis

Key Players Analysis:

1.    Abbvie
2.    Sientra Inc.
3.    Hans Biomed Co., Ltd
4.    Establishment Labs SA
5.    Guangzhou Wanhe Plastic Materials Co.
6.    Ideal Implant Inc.
7.    Laboratoires Arion
8.    Polytech Health & Aesthetics GmbH
9.    Mentor Worldwide LLCs
10.    Sebbin

Report Details: